Nuzenio

Tradingview Inmb

Tradingview Inmb entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 6 latest news signals 1 publisher sources 100/100 entity strength

Latest news

INMB: Ebstrocel nears global filings as financials strengthen and XPro advances in Alzheimer's - TradingViewTradingView · Thu, 06 Aug 2026 21:30:58 GMTINmune Bio Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 21:01:30 GMTInmune Bio, Inc. Q2 2026: Revenue $0 Net loss $(1.27)M, EPS $(0.05) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:11:01 GMTINMB: Regulatory progress and clinical advances drove a sharply reduced net loss and strengthened outlook - TradingViewTradingView · Thu, 06 Aug 2026 00:40:00 GMTINMB Q2'26 Earnings: EPS estimate is (0.21) USD - TradingViewTradingView · Wed, 05 Aug 2026 11:01:57 GMTINmune Bio receives ~$4.6M in R&D rebates, cash proceeds exceed Q2 operating cash use - TradingViewTradingView · Fri, 31 Jul 2026 20:13:01 GMT

Timeline

Thu, 06 Aug 2026 21:30:58 GMTINMB: Ebstrocel nears global filings as financials strengthen and XPro advances in Alzheimer's - TradingView
Thu, 06 Aug 2026 21:01:30 GMTINmune Bio Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView
Thu, 06 Aug 2026 20:11:01 GMTInmune Bio, Inc. Q2 2026: Revenue $0 Net loss $(1.27)M, EPS $(0.05) — 10-Q Summary - TradingView
Thu, 06 Aug 2026 00:40:00 GMTINMB: Regulatory progress and clinical advances drove a sharply reduced net loss and strengthened outlook - TradingView
Wed, 05 Aug 2026 11:01:57 GMTINMB Q2'26 Earnings: EPS estimate is (0.21) USD - TradingView
Fri, 31 Jul 2026 20:13:01 GMTINmune Bio receives ~$4.6M in R&D rebates, cash proceeds exceed Q2 operating cash use - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Inmb.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.